Research participants as 'pioneers'? Exploring how neurotechnology research is adapting the rhetoric of scientific risk-taking, exploration and trailblazing.
The theme of pioneers charting new frontiers has long been a staple of scientific and technological discourse in the United States. Scientists, engineers and entrepreneurs perceived as doing groundbreaking work are lauded as pioneers in their fields. In recent years, the application of the pioneer l...
| Publicado en: | Science as Culture Vol. 35; no. 2; pp. 218 - 245 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Taylor & Francis Ltd
Jun2026
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=195471735&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 195471735 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 09505431 10W jtl: Science as Culture issn: 09505431 maglogo: N pubinfo: dt: Jun2026 vid: 35 iid: 2 pid: 377 pub: Taylor & Francis Ltd artinfo: ui: 195471735 10.1080/09505431.2026.2673139 ppf: 218 ppct: 27 formats: tig: atl: Research participants as 'pioneers'? Exploring how neurotechnology research is adapting the rhetoric of scientific risk-taking, exploration and trailblazing. aug: au: Brown, Andrew Ivan Goering, Sara Klein, Eran affil: Centre for Biomedicine, Self and Society, University of Edinburgh, Scotland, UK Department of Philosophy, University of Washington, Seattle, WA, USA Department of Neurology, Oregon Health & Science University, Portland, OR, USA su: United States Human research subjects Clinical trials Courage Technological innovations Neurotechnology (Bioengineering) Brain-computer interfaces Scientific language Human experimentation sug: subj: Human research subjects Clinical trials Courage Technological innovations United States Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) Neurotechnology (Bioengineering) Brain-computer interfaces Scientific language Human experimentation keyword: naming Neuralink Neuroethics qualitative science and technology studies technology journalism naming Neuralink Neuroethics qualitative science and technology studies technology journalism ab: The theme of pioneers charting new frontiers has long been a staple of scientific and technological discourse in the United States. Scientists, engineers and entrepreneurs perceived as doing groundbreaking work are lauded as pioneers in their fields. In recent years, the application of the pioneer label has expanded to include research participants in clinical trials for neurotechnologies such as Neuralink or other brain-computer interface (BCI) devices: 'BCI pioneers.' What might explain this new popular usage of the pioneer label? American science policy in the mid twentieth century drew on the mythos of the American frontier as a way of mobilizing public interest in scientific and technological innovation on a mass scale. One such way of mobilizing interest was to use frontier rhetoric to attribute novelty to scientific undertakings and technological developments: dubbed the new frontiers. A less explored aspect of this history is the application of the pioneer label to patients and research participants in scientific, mostly biomedical, studies. Through the use of frontier rhetoric, articulations of novelty can be attributed to patients and participants, and their participatory practices, including being the first to undergo a new medical procedure, as well as being explorers and trailblazers in their own right. Such rhetoric may be understood as mobilizing support for research participants by acknowledging their bravery, altruism and contributions to science, with implications for participatory science and scientific and technological innovation. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|